Metformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for ...

Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed SGLT2 inhibitor for type-2 diabetes ...

Intensive management of diabetes pays fewer dividends as patients age and raises the chances of hypoglycemia. But many people ...

Alkem Laboratories launches generic empagliflozin in India as Empanorm, offering affordable treatment for diabetes and ...

The price of commonly used diabetes drug empagliflozin has been slashed by almost one-tenth, with the entry of its generic ...

India’s drug price regulator has capped retail prices for 53 drug formulations used in treating various diseases and ...

Generic medicines were sold at a discount of 20% to 90% and other medicines were sold at 25% discount. For example, metformin tablets provided to diabetic patients were sold at ₹70 by private ...

Several domestic drug makers, including Mankind Pharma, have launched the diabetes drug Empagliflozin at significantly ...

Generic versions of diabetes drug Empagliflozin launched in India, crashing prices by 80-90% on day one post-patent expiry.

Alkem Laboratories Ltd announced the launch of generic empagliflozin and its combinations in India under the brand name “Empanorm” at prices that are approximately 80% lower than the innovator ...

Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...

The National Pharmaceutical Pricing Authority (NPPA) has notified the retail price of 53 new drugs based on applications submitted by individual companies, after finalising the same in the latest ...